聚焦VaIN2+:基于大型阴道镜人群的预测列线图开发与验证
本研究基于3259例接受阴道镜检查的女性,回顾性分析VaIN2+的临床特征与HPV基因型分布,并开发预测列线图。模型纳入年龄、子宫切除史、特定HPV基因型及细胞学结果等10个独立预测因子。列线图在训练集AUC为0.771,验证集AUC为0.791,可为个体化VaIN2+风险评估提供工具。
要点
- 年龄较大、HPV感染、细胞学≥ASCUS及并发宫颈/外阴病变者VaIN2+风险更高。
- HPV16、58、52、33、18是VaIN2+人群最常见基因型。
- 列线图整合10个预测因子,可用于个体化VaIN2+风险评估。
核心结论
- 该研究开发了首个整合特定HPV基因型与多种临床因素的VaIN2+预测模型,有助于临床主动识别高风险个体。
研究设计与样本
- 回顾性分析2012年9月至2024年12月单中心3259例接受阴道镜检查女性的临床特征与HPV基因型分布。
- 通过LASSO回归初筛预测因子,并经多因素logistic回归最终确定,在训练集和验证集中评估模型区分度、校准度与临床效用。
主要发现
- 1192例VaIN2+女性中,年龄较大、HPV感染、细胞学≥ASCUS及并发宫颈/外阴病变较2067例无阴道病变者更常见。
- HPV16、HPV58、HPV52、HPV33和HPV18为VaIN2+人群最常见基因型。
- 列线图在训练集AUC为0.771,验证集AUC为0.791,校准满意,决策曲线分析显示在较宽阈值概率范围内具有优越的临床净获益。
关键数值与推荐
- 10个独立预测因子包括:年龄、子宫切除史、特定HPV基因型(16、58、56、35、39)、细胞学结果(ASCUS及以上)、并发宫颈病变(CIN1、CIN2/3、宫颈鳞癌)及并发外阴病变。
临床怎么用
- 该列线图可用于阴道镜检查人群的个体化VaIN2+风险评估,辅助临床主动筛查高风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Based on data from 3259 women, this study identified older age, history of hysterectomy, specific HPV genotypes, abnormal cytology, and concurrent cervical/vulvar lesions as independent risk factors for VaIN2+ and incorporated them into a nomogram. This nomogram provides individualized VaIN2+ risk assessment to facilitate proactive identification of high-risk individuals. Abstract Introduction Vaginal intraepithelial neoplasia 2 or worse (VaIN2+) has long remained in a largely passive diagnostic pattern due to the lack of specific clinical manifestations and routine screening strategies. This study aimed to explore its clinical characteristics and develop a prediction model for individualized risk assessment. Material and Methods We retrospectively analyzed the clinical characteristics and human papillomavirus (HPV) genotype distribution in 3259 women undergoing colposcopy at a single center between September 2012 and December 2024. A nomogram was developed based on predictors initially screened by least absolute shrinkage and selection operator regression and finalized through multivariable logistic regression. The model's discriminative ability, calibration, and clinical utility were assessed in both training and validation sets. Results Among 1192 women with VaIN2+, older age, HPV infection, cytology worse than atypical squamous cells of undetermined significance (ASCUS), and concurrent cervical/vulvar lesions were more prevalent than in 2067 women without vaginal lesions. HPV16, HPV58, HPV52, HPV33, and HPV18 were the most common genotypes. A nomogram was developed based on 10 independent predictors identified by multivariable analysis, including age, hysterectomy history, specific HPV genotypes (16, 58, 56, 35, 39), cytological results (ASCUS and worse), concurrent cervical lesions (cervical intraepithelial neoplasia 1, cervical intraepithelial neoplasia 2 or 3, cervical squamous cell carcinoma), and concurrent vulvar lesions. The nomogram demonstrated good discrimination, with an area under the receiver operating characteristic curve of 0.771 in the training set and 0.791 in the validation set. Calibration was satisfactory, and decision curve analysis confirmed superior clinical net benefit across a wide threshold probability range. Conclusions By profiling VaIN2+ characteristics, this study developed the first prediction model integrating specific HPV genotypes with multiple clinical factors. This model enables clinicians to proactively identify hig
引用
- Acta Obstetricia et Gynecologica Scandinavica:Focusing on VaIN2+: Development and validation of a prediction nomogram based on a large colposcopy population
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。